Recipients are University of California at Berkeley biochemist Jennifer Doudna and Emmanuelle Charpentier of France
WEDNESDAY, Oct. 7, 2020 (HealthDay News) — American and French scientists have won the 2020 Nobel Prize in chemistry for their work developing the revolutionary gene-editing tool CRISPR-Cas9.
The award for University of California at Berkeley biochemist Jennifer Doudna and Emmanuelle Charpentier of France was announced Wednesday, The Washington Post reported.
“This year’s prize is about rewriting the code of life,” said Goran Hansson, secretary general of the Royal Swedish Academy of Sciences.
CRISPR-Cas9 — often described as molecular scissors — can locate and snip out specific sections of DNA and is being investigated as a cancer therapy and a cure for inherited diseases, The Post reported.
Gene Mutation Identified That Increases Lung Cancer Risk 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population 
Relapse Rare After Appendiceal Adenocarcinoma Resection 
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction .jpg)
Cancer Survivors Have Lower Levels of Physical Activity 
Early Complications Common in Older Kidney Transplant Recipients 
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer 
